ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,345Medicare Part D Prescriptions Filled, Including Refills

Rank: 100 out of 617

$710K Total Retail Price of All Prescriptions

Rank: 28 out of 617

394 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 394 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 394 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 8,846 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
WARFARIN SODIUM 429 414 1 7
LEVOTHYROXINE SODIUM 427 379 2 1
CRESTOR 365 348 3 28
LISINOPRIL 309 298 4 5
HYDROCODONE-ACETAMINOPHEN 296 214 S3 5 8
PRAVASTATIN SODIUM 279 260 6 21
CARVEDILOL 263 239 7 19
AMLODIPINE BESYLATE 231 203 8 6
SIMVASTATIN 220 193 9 2
FUROSEMIDE 207 196 10 4
METOPROLOL SUCCINATE 206 192 11 12
OMEPRAZOLE 203 158 12 3
METFORMIN HCL 180 156 13 9
GABAPENTIN 164 139 14 16
ZOLPIDEM TARTRATE 161 139 15 23
ATORVASTATIN CALCIUM 142 142 16 14
HYDROCHLOROTHIAZIDE 139 127 17 13
JANUVIA 133 117 18 107
ALLOPURINOL 132 120 19 27
ZETIA 121 107 20 77
BYSTOLIC 112 100 21 64
DIOVAN 109 109 22 41
TAMSULOSIN HCL 102 95 23 26
FENTANYL 93 24 S2 24 45
AMLODIPINE BESYLATE-BENAZEPRIL 93 80 24 80
ADVAIR DISKUS 91 66 26 38
LOSARTAN POTASSIUM 90 90 27 22
METOPROLOL TARTRATE 87 76 28 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 81 29 29
EXFORGE 78 78 30 193
CYMBALTA 74 60 31 49
LANTUS SOLOSTAR 73 53 32 115
CELEBREX 72 60 33 63
SINGULAIR 72 59 33 106
FENOFIBRATE 72 30 33 58
SPIRIVA 72 72 33 61
LANTUS 71 69 37 39
POTASSIUM CHLORIDE 68 63 38 10
TRIAMCINOLONE ACETONIDE 64 62 39 102
PREDNISONE 62 59 40 31
SERTRALINE HCL 61 48 41 20
TRAMADOL HCL 61 48 41 15
PANTOPRAZOLE SODIUM 59 54 43 37
CLOPIDOGREL 57 57 44 53
ALBUTEROL SULFATE 57 57 44 112
WELCHOL 55 54 46 170
ALENDRONATE SODIUM 54 50 47 25
METFORMIN HCL ER 54 41 47 72
CITALOPRAM HBR 54 52 47 18
PLAVIX 54 54 47 86
FLUTICASONE PROPIONATE 54 45 47 36
ATENOLOL 53 53 52 17
CLONIDINE HCL 51 51 53 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.